Since the start of the year, Humana stock is underperforming with a 39.4% deficit. The $300 level, which provided support ...
Late last year, The Wall Street Journal reported that Cigna was in talks with Humana for a healthcare merger but abandoned its pursuit after shareholders balked at a deal that would have created a ...
Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA ...
Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Whit Mayo ...
As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...
Stocktwits on MSN4d
US Election 2024: BoFA Securities Revamps Ratings On Humana, UHS, Ardent, Oscar Health Stocks After Trump WinSecurities updated its ratings on several healthcare stocks, according to thefly.com, indicating a mixed outlook for the ...
As previously reported, BofA upgraded Humana (HUM) to Neutral from Underperform with a price target of $308, up from $247, on the results of ...
Shares of Humana Inc. HUM rose 1.98% to $260.60 Tuesday, on what proved to be an all-around favorable trading session for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback